ST. LOUIS ( - A study conducted by Washington University shows that a drug prescribed for depression and related conditions may prevent COVID-19 patients from developing serious symptoms.

According to the study, fluvoxamine, which is used for depression, anxiety and obsessive compulsive disorder, prevented serious complications, and made the need for hospitalization and oxygen less likely in COVID-19 patients.

The study involved 152 COVID-19 patients recovering at home, 80 patients were given the drug and 72 were given the placebo over a two-week period.

Six of 72 patients who received a placebo became seriously ill; four were sent to a hospital. None of 80 patients who took fluvoxamine got seriously ill.

A larger study on the drug and its effect on COVID-19 patients will be starting soon.


Recommended for you

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.